News
Drug Information Association
DIA course on Benefit – Risk Management on 19 & 20 May, 2011 in Prague. This course will be conducted by Jan-Willem van der Velden en Jan Petracek in the Radisson Blu Alcron Hotel (DIA course #11562).
Post Date: 26-04-2011
EU Clinical Trials Register goes live
The EU Clinical Trials Register went live today. More information and access can be found via the this link.
Post Date: 13-04-2011
Drug Information Association
During the Pre-Conference Tutorials on Monday, 28 March 2011 in Geneva at the EURO-DIA meeting, Jan-Willem will give an INTRODUCTION TO CRISIS MANAGEMENT
In this introductory tutorial the participant will be made familiar with the definition of a crisis and understand which processes in their own working environment could be vulnerable for possible crises. Examples are given and participants are invited to join in exercises and learn which parties are all involved within and outside their organisation. The participant will be provided with the tools with which to plan for a potential crisis and how to build a preventive strategy. The roles of the Crisis Management Team members are shown and examples are given of right and wrong actions, including attitude towards the media.
Post Date: 05-03-2011
Message from ENCePP
We would like to inform you that the European Medicines Agency (EMA) has released for public consultation a draft European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) 'Guide on Methodological Standards in Pharmacoepidemiology'.This guideline has been developed by ENCePP, a collaboration between the EMA and the pharmacoepidemiology research community that aims to strengthen the post-authorisation monitoring of medicines by facilitating the conduct of multi-centre, independent and scientifically robust studies focusing on safety and the balance of benefits and risks...
Post Date: 16-11-2010
| Full
Story
10th annual meeting, International Society of Pharmacovigilance
Jan-Willem will lead a workshop on ‘Pharmacovigilance and Vaccines’ at the 10th annual meeting of the International Society of Pharmacovigilance in Accra, Ghana on November 6th.
Post Date: 15-09-2010
Drug Information Association
Jan-Willem van der Velden and Michael Forstner will give a DIA course in Crisis Management on
October 14&15 in Paris, France. View the agenda.
Post Date: 10-04-2010 |
Edit Date: 04-05-2010
Drug Information Association
Jan-Willem
will give a presentation at the DIA 22nd Annual EuroMeeting in Monaco. The
current title is SAFETY: EVIDENCE & STUDY DESIGNS IN PERSONALISED MEDICINES
[Drug Plasma Levels and ADR?s: usefulness of the TDMplus algorithm] (Mar 10,
2010 at 9:00AM).
Post Date: 11-01-2010
Swiss Society of Pharmaceutical Medicine
At their general assembly of
November 25, 2009 in Lausanne Switzerland, Jan-Willem has been elected as board
member of the SGPM/ASMP: the Swiss Society of Pharmaceutical Medicine. (www.sgpm.ch).
Post Date: 29-11-2009
ENCePP public consultation
Mesama
Consulting
would like to inform you that the European Medicines Agency (EMEA) has
released for public consultation a draft Code of Conduct for Independence
and Transparency, and a draft Checklist of Methodological Research Standards
that lay down key elements and principles for the conduct of "European
Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
studies".
Post Date: 19-11-2009| Full
Story
9th annual meeting, International Society of
Pharmacovigilance
Jan-Willem
gives a presentation on Integrated Drug Safety Solutions at the 9th annual
meeting of the International Society of Pharmacovigilance in Reims, France
on October 8th.
Post Date: 05-10-2009
Announcement of European Medicines Agency priorities for adverse drug reaction research
At its plenary meeting on 19 March 2009, the European Medicines Agency?s Committee for Medicinal Products for Human Use (CHMP) adopted its 2010 priorities for drug safety research based on recommendations from the CHMP?s Pharmacovigilance Working Party. The priorities were developed with a view to them being considered as future topics for the 4th Call of the European Commission?s 7th Framework Programme (FP7).On 30 July 2009, the Commission published several calls for proposals of FP7 including three calls under the ?Health? Theme. The priorities for adverse drug reaction research are reflected in the call ?FP7-HEALTH-2010-single-stage?, call topic HEALTH.2010.4.2-3, Adverse drug reaction research and the European Medicines Agency now wishes to release complementary information with the aim to support researchers in developing proposals that meet the needs of the respective selected research.
Post Date: 26-08-2009 | Full
Story
Contact Information
Jan-Willem van der Velden, Dr. med.Bruggerstrasse 29
5116 Schinznach Bad
Switzerland
Tel/Fax: +41 (0)56 443 0689
Mobile: +41 (0)79 664 9982
info@mesama-consulting.com
You are vistor
Disclaimer - Copyright © 2012 - Designed by Misja van der Velden